Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes
AssigneeAjinomoto Co., Inc.
InventorsJunji Hamuro, Yukie Murata
Life of this patent
Estimating the term…
Abstract
A method of suppressing immune responses, comprising administering to a patient in need thereof an effective amount of a composition comprising a substance capable of reducing the content of reductive glutathione in macrophages.
Claims54
1-19. (canceled)
A method of inducing a Th2 response in a subject, wherein the subject is suffering from at least one of gastrointestinal inflammatory disease, hepatitis, or hepatic cirrhosis, comprising administering to the subject an effective amount of the cystine derivative represented by formula (I):
- wherein
- R1 and R2, independently from each other, represent an alkyl group or a substituted alkyl group, and
- R3 and R4, independently from each other, represent an acyl group or a peptidyl group.
A method of inducing a Th2 response in a subject, comprising administering to the subject an effective amount of the cystine derivative represented by formula (I):
- wherein
- R1 and R2, independently from each other, represent an alkyl group or a substituted alkyl group, and
- R3 and R4, independently from each other, represent an acyl group or a peptidyl group, wherein at least one of R3 and R4 is a peptidyl group having 1 to 10 amino acids.
A method suppressing cellular immune responses in a subject by skewing the Th1/Th2 balance to Th2, wherein the subject is suffering from at least one of gastrointestinal inflammatory disease, hepatitis, or hepatic cirrhosis, comprising administering to the subject an effective amount of the cystine derivative represented by formula (I):
- wherein
- R1 and R2, independently from each other, represent an alkyl group or a substituted alkyl group, and
- R3 and R4, independently from each other, represent an acyl group or a peptidyl group.
A method of suppressing cellular immune responses in a subject by skewing the Th1/Th2 balance to Th2, comprising administering to the subject an effective amount of the cystine derivative represented by formula (I):
- wherein
- R1 and R2, independently from each other, represent an alkyl group or a substituted alkyl group, and
- R3 and R4, independently from each other, represent an acyl group or a peptidyl group, wherein at least one of R3 and R4 is a peptidyl group having 1 to 10 amino acids.
Dependencies are inferred from the claim text.